FDA approves Roche’s new generation breast cancer-fighting drug

Called Kadcyla, the medication was reported to have minimal side effects in a clinical trial but will carry a warning label on the box

Continued here:
FDA approves Roche’s new generation breast cancer-fighting drug

Leave a Reply